NCT06141772 Kinetics of Circulating Tumor DNA in Lymphoma Treated by Immuno-chemotherapy Status COMPLETED Phase NA
NCT06131801 Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution Status RECRUITING Phase N/A
NCT06081478 CD19/CD22 Bispecific CAR-T Cell Therapy for Relapsed/Refractory B-cell Lymphoma or Acute Lymphoblastic Leukemia Status RECRUITING Phase PHASE2
NCT06022029 A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas. Status RECRUITING Phase PHASE1
NCT06005870 Zanubrutinib Combined With R-CHOP in the Treatment of Newly Diagnosed DLBCL With p53 Protein Expression Status RECRUITING Phase PHASE2
NCT05990465 LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies Status RECRUITING Phase PHASE1
NCT05958134 Brazilian Reality in the Diagnosis and Treatment of Diffuse Large B Cell Lymphoma - BRA-DLBCL Status COMPLETED Phase N/A
NCT05940064 Prospective Clinical Study of ZPR Regimen in Elderly Treatment-naive Diffuse Large B-cell Lymphoma Status RECRUITING Phase PHASE2
NCT05940051 Prospective Clinical Study of ZPR Regimen in Relapsed/Refractory Diffuse Large B-cell Lymphoma Status RECRUITING Phase PHASE2
NCT05934838 A Feasibility Trial of Tazemetostat Plus CAR T Cell Therapy in B-cell Lymphomas Status RECRUITING Phase PHASE1
NCT05934097 FT596 in Combination With R-CHOP in Subjects With B-Cell Lymphoma Status WITHDRAWN Phase PHASE1
NCT05923502 (CHANT)Real World Study of Duvelisib in the Treatment of Non-Hodgkin's Lymphoma (NHL) Status NOT_YET_RECRUITING Phase N/A
NCT05907447 A Retrospective Study on Extranodal Lymphoma or Lymphoma of Rare Pathological Types Status UNKNOWN Phase N/A
NCT05887726 Zanubrutinib Combined With R-CHOP Regimen in the Treatment of Newly Diagnosed DLBCL With High-risk Factors Status UNKNOWN Phase PHASE2
NCT05887167 Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies Status RECRUITING Phase PHASE1
NCT05863845 Efficacy and Safety of Venetoclax Combined With BEAM Pretreatment in Autologous Transplantation for DLBCL Status NOT_YET_RECRUITING Phase NA
NCT05834426 Omic Technologies Applied to the Study of B-cell Lymphoma for the Discovery of Diagnostic and Prognosis Biomarkers Status NOT_YET_RECRUITING Phase N/A